| Line Item | 2025-09-05 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $21K | — | — |
| Gross Profit | $21K | — | — |
| R&D Expense | $16K | — | — |
| SG&A Expense | $1.4M | — | — |
| Operating Income | -$1.5M | — | — |
| Net Income | -$2.6M | — | — |
| EPS (Basic) | -$0.10 | — | — |
| EPS (Diluted) | -$0.10 | — | — |
| Line Item | 2025-09-05 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.2M | — | — |
| Current Assets | $3.7M | — | — |
| Total Assets | $9.9M | — | — |
| Current Liabilities | $19.3M | — | — |
| Total Liabilities | $19.4M | — | — |
| Stockholders' Equity | -$9.6M | — | — |
| Line Item | 2025-09-05 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.4M | — | — |
| Capital Expenditures | $1K | — | — |
| Investing Cash Flow | $543K | — | — |
| Financing Cash Flow | $6.0M | — | — |
| Free Cash Flow | -$3.4M | — | — |